The low-molecular-weight stimulator of phosphofructokinase [Van Schaftingen, Hue & Hers (1980) Biochem. J. 192, 887-895] has been purified from rat liver. It was completely destroyed upon incubation with 0.01 M-HCl for 10 min at 20 degrees C and fructose 6-phosphate and a reducing power equivalent in amount to the acid-labile organic phosphate were formed. It was therefore tentatively identified as fructose 2,6-bisphosphate.
Fructose 2,6-bisphosphate, the probable structure of the glucose-and glucagon-sensitive stimulator of phosphofructokinase The low-molecular-weight stimulator of phosphofructokinase [Van Schaftingen, Hue & Hers (1980) Biochem. J. 192, 887-895] has been purified from rat liver. It was completely destroyed upon incubation with 0.01 M-HCl for 10min at 200C and fructose 6-phosphate and a reducing power equivalent in amount to the acid-labile organic phosphate were formed. It was therefore tentatively identified as fructose 2,6-bisphosphate.
Several groups of workers (Castanio et al., 1979; Pilkis et al., 1979; Kagimoto & Uyeda, 1979) have reported that incubation of isolated hepatocytes in the presence of glucagon caused a decrease in the activity of phosphofructokinase measured at subsaturating concentrations of fructose 6-phosphate. This change was reported to be stable upon gel filtration as well as upon partial purification. We have recently observed (Van Schaftingen et al., 1980 ) that a similar change could be obtained by gel filtration of a liver extract and could be reversed by the addition of the low-molecular-weight fraction.
We have also reported that the substance responsible for this effect is acid labile even at 0°C but could be separated from proteins by ultrafiltration of a liver homogenate or by heating at 800C followed by centrifugation. The stimulator has a molecular weight similar to that of fructose 1,6-bisphosphate and was destroyed by incubation in the presence of alkaline phosphatase; it appeared therefore to be an acid-labile phosphoric ester.
In the present paper we report other properties of the stimulator, which indicate that it is probably fructose 2,6-bisphosphate.
Materials and methods

Chemicals and enzymes
Inorganic pyrophosphatase and rabbit muscle phosphofructokinase were obtained from Boehringer (Mannheim, Germany) 
A nalyticalprocedures
Reducing sugars were determined as described by Park & Johnson (1949) . Phosphate was assayed by the sensitized method developed by Itaya & Ui (1966) ; the absorbance was read 15min after the addition of the colour-developing reagent, which contained no detergent. Pyrophosphate was determined as phosphate after incubation for 15min with pyrophosphatase (2units/ml) in the presence of 1.2mM-MgCl2 and 50mM-Tris/HCI adjusted to pH7.0. Esterified phosphate was determined after hydrolysis by alkaline phosphatase; samples were incubated at 300C for 30min with 2 units of calf intestine alkaline phosphatase/ml in the presence of 0.25 mM-ZnCl2, 2.5 mM-MgCl2 source of other chemicals and reagents were as described elsewhere (Van Schaftingen et al., 1980) .
Results
Purification of the stimulator of phosphofructokinasefrom rat liver When designing the following purification procedure, we took into consideration the fact (Van Schaftingen et al., 1980 ) that perfusion of a liver at a high concentration of glucose considerably increased its content of stimulator. We also knew that the stimulator does not resist acid extraction or boiling, but that it can be extracted at 800C. Since the stimulator was expected to be a phosphoric ester, we applied the classical methodology used to isolate this type of compound (Cardini & Leloir, 1957) .
Extraction from the liver. Well-fed rats were anaesthetized and their livers were perfused for 20min with Krebs-Henseleit (1932) The amount of barium precipitate obtained from 250ml of the original (heat-treated) extract was suspended in 25 ml of water at 0-40 C and shaken in the presence of 5 g of Chelex. After 15 min, the mixture was centrifuged and the sediment was extracted again with another 25 ml of water and centrifuged. The supernatants were combined and passed through a column (1.4cm x 3 cm) of Chelex and, immediately afterwards, through a column (0.9cm x 20cm) of Dowex AG 1 (X8; Cl-form) and a gradient of NaCl at 0-40C (0-500mM in 300 ml) was applied. The stimulator was eluted after glucose 6-phosphate and inorganic phosphate at a concentration of NaCl of approx. 220 mm. The active fractions were combined, diluted with 2 vol. of water and chromatographed again on Dowex with an NaCl gradient (100-400mM in 200ml). Except for the volume of liquid contained in the charcoal and glycogen pellets, the recovery of the stimulator through this purification procedure was nearly complete.
Acid hydrolysis and treatment with fructose bisphosphatase
The extreme acid-lability of the stimulator of phosphofructokinase (Van Schaftingen et al., 1980) is illustrated in Fig. 1 
Purity and tissue concentration
The presence of an acid-labile fructose 6-phosphate moiety in the stimulator allows one to assay it on a molar basis. We show in Fig. 2 that, upon anion exchange chromatography, the stimulatory property was eluted in parallel with acid-labile phosphate, and with the acid-liberated fructose 6-phosphate and reducing power in nearly equimolar concentrations. [Stimulator] (pM) Fig. 3 . Dose-response curve of liver phosphofructokinase to its stimulator The concentration of stimulator was estimated by the amount of fructose 6-phosphate liberated by hydrolysis.
1,6-bisphosphate nor pyrophosphate are major contaminants. When a tracer amount of fructose 1,6-bisphosphate was added to the mixture before chromatography, it was eluted slightly before the stimulator (Fig. 2) .
As reported elsewhere (-Van Schaftingen et al., 1980 ) the concentration of the stimulator of phosphofructokinase in isolated hepatocytes, as assayed by its biological properties, varied greatly according to whether glucose or glucagon were present in the incubation medium. The determination of the amount of fructose 6-phosphate liberated in 0.01 M-HCI allows us to calculate that approximately 5 nmol of stimulator were obtained from 1 g of liver through the procedure described above. The concentration of the stimulator is therefore approx. 5 x 10-6M in the liver perfused with 50mM-glucose. This concentration is known to be at least 10-fold lower after treatment of the liver with glucagon (Van Schaftingen et al., 1980) , although the biological assay used was not sensitive enough to detect very low concentrations.
Effect of stimulator concentration on liver and musclephosphofructokinase Fig. 3 shows the saturation of liver phosphofructokinase by the stimulator. The enzymic preparation used was a Sephadex filtrate obtained from the liver of a fed rat. The effect was half-maximal at about 10-7M (expressed as fructose 6-phosphate liberated by hydrolysis). A similar effect with similar doses was obtained with purified muscle phosphofructokinase (results not shown).
Discussion
The stimulator of phosphofructokinase present in livers perfused with glucose at a high concentration was known to be a highly acid-labile phosphoric ester whose molecular weight is close to that of fructose 1,6-bisphosphate (Van Schaftingen et al., 1980) . The facts that it is not adsorbed on charcoal, that it is barium-insoluble and that it is eluted from anion exchangers after monophosphoric esters and inorganic phosphate are all in agreement with the hypothesis that the stimulator is a non-nucleotidic diphosphoric ester.
The remarkable parallelism that was observed in the course of limited acid hydrolysis between the loss of the stimulator and the appearance of fructose 6-phosphate together with an equivalent amount of reducing power indicates that fructose 6-phosphate is a constituent of the stimulator, in which its reducing group is hidden. The parallelism between the amount of stimulator and acid-liberated reducing power and fructose 6-phosphate in the elution profile strengthens this view. There was no such a parallelism with the elution of the reducing power measured before acid treatment; furthermore, the amount of this reducing power was too small to account for the hidden fructose 6-phosphate. We therefore conclude that the stimulator is a nonreducing derivative of fructose 6-phosphate.
The parallelism between the elution of the stimulator and that of the acid-labile phosphate, in a concentration equimolar to that of the acid-liberated fructose 6-phosphate, indicates that phosphate is another moiety of the stimulator. To account for the absence of reducing power and for the remarkable lability in acid medium, one has to assume that this phosphate is esterified at position 2 of fructose 6-phosphate. Indeed, furanosylphosphates such as ribose 1-phosphate (Kalckar, 1947) and ribose 1,5-bisphosphate (Klenow, 1953) are known to be acid-labile at low temperature. We therefore propose that the stimulator of phosphofructokinase is fructose 2,6-bisphosphate. The structure proposed may, however, be incomplete and nothing is known about the anomeric form.
The effect of the stimulator is half-maximal at about 10-7M and its concentration in the liver is in the same range. This range of concentration is similar to that of cyclic AMP. The fact that the stimulator acts equally well on crude liver phosphofructokinase and on the purified muscle enzyme indicates that its biological action may extend to tissues other than the liver. It is not known at the present time if it extends to reactions other than that catalysed by phosphofructokinase. 
